SC
LMAT icon

Stephens Consulting’s LeMaitre Vascular LMAT Stock Holding History

Stephens Consulting’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$839 – 1629
2025
Q1 		$839 Buy
+10
New +$930 ﹤0.01% 729

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Stephens Consulting's LMAT Position: Q2 2025 in Review

Stephens Consulting sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 10 shares — an estimated $839 sold.

Stephens Consulting first reported a position in LMAT in Q1 2025 and held it in 1 quarter. The position peaked at $839 in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Stephens Consulting reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 10 LeMaitre Vascular shares in Q2 2025, an estimated $839.
  • Stephens Consulting first reported a position in LeMaitre Vascular in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's LeMaitre Vascular position peaked at $839 in Q1 2025.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.